-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Is this participant eligible for ART?
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Will Atripla be appropriate if relevant laboratory investigations are normal?
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise
-
Treatment as Prevention ANRS 12249, phase 1
South Africa · 2012–2014 · ANRS12249 · Dabis, François, Newell, Marie-Louise